Last updated on July 2019

Study to Assess the Efficacy and Safety of CLBS12 in Patients With Critical Limb Ischemia (CLI)


Are you eligible to participate in this study?

You may be eligible for this study if you meet the following criteria:

  • Conditions: Critical Limb Ischemia | Thromboangiitis Obliterans | Atherosclerosis Obliterans
  • Age: Between 20 - 80 Years
  • Gender: Male or Female

Inclusion Criteria:

  • subject has CLI caused by ASO or BD

Exclusion Criteria:

  • < 20 years old

Recruitment Status: Open


Brief Description Eligibility Contact Research Team


Volunteer Sign-up

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.